Y-Intercept (HK)’s Orchestra BioMed OBIO Stock Holding History

Y-Intercept (HK)’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$188K	Buy	+43,486	New	+$178K	﹤0.01%	1579
2025 Q3	–	Sell	-45,447	Closed	-$122K	–	1899
2025 Q2	$122K	Buy	+45,447	New	+$133K	﹤0.01%	1518

Other funds holding OBIO

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Meramec Financial Planners Saint Louis, Missouri $274M AUM

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ABLE Financial Group Scottsdale, Arizona $596M AUM 23.3% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

Y-Intercept (HK)'s OBIO Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 43,486 shares worth $188K. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in OBIO as recently as Q2 2025.

Y-Intercept (HK) first reported a position in OBIO in Q2 2025 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

Y-Intercept (HK) held 43,486 shares of Orchestra BioMed worth $188K as of Q2 2026.
Orchestra BioMed was a new Y-Intercept (HK) position in Q2 2026.
Orchestra BioMed made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1579 holding.
Y-Intercept (HK) first reported a position in Orchestra BioMed in Q2 2025 and has held it in 2 quarters since.
13 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.